Gügi Bruno, Le Costaouec Tinaïg, Burel Carole, Lerouge Patrice, Helbert William, Bardor Muriel
Laboratoire Glyco-MEV EA 4358, Université de Rouen, Normandie Université, Institut de Recherche et d'Innovation Biomédicale (IRIB), Végétale Agronomie Sol Innovation (VASI), Normandie Université, Faculté des Sciences et Techniques, 76821 Mont-Saint-Aignan, France.
CNRS, Centre de Recherches sur les Macromolécules Végétales (CERMAV), Université Grenoble Alpes, CERMAV, F-38000 Grenoble, France.
Mar Drugs. 2015 Sep 18;13(9):5993-6018. doi: 10.3390/md13095993.
Diatoms are marine organisms that represent one of the most important sources of biomass in the ocean, accounting for about 40% of marine primary production, and in the biosphere, contributing up to 20% of global CO₂ fixation. There has been a recent surge in developing the use of diatoms as a source of bioactive compounds in the food and cosmetic industries. In addition, the potential of diatoms such as Phaeodactylum tricornutum as cell factories for the production of biopharmaceuticals is currently under evaluation. These biotechnological applications require a comprehensive understanding of the sugar biosynthesis pathways that operate in diatoms. Here, we review diatom glycan and polysaccharide structures, thus revealing their sugar biosynthesis capabilities.
硅藻是海洋生物,是海洋中最重要的生物质来源之一,约占海洋初级生产力的40%,在生物圈中,贡献高达20%的全球二氧化碳固定量。最近,将硅藻用作食品和化妆品行业生物活性化合物来源的应用开发激增。此外,三角褐指藻等硅藻作为生物制药生产细胞工厂的潜力目前正在评估中。这些生物技术应用需要全面了解硅藻中运行的糖生物合成途径。在这里,我们综述了硅藻聚糖和多糖结构,从而揭示它们的糖生物合成能力。